Rising bond yields are dragging the whole market down, but the AI buildout is generating real, contracted revenue — Akamai's $12 billion Anthropic deal and Accenture's $1 billion AI partnership show enterprise AI budgets are being spent at scale, and Meta

Verdict: contracted AI demand is real, but the entry hasn't armed yet

The verdict is **wait, not buy**. The strongest point for this idea is real, contracted demand — Akamai's $12B Anthropic computing deal (per Bloomberg, September 24) and Accenture's $1B AI partnership (per Yahoo Finance, September 23) are signed commitments, and Accenture's latest quarter (ended May 31, 2026) showed revenue up 3.7% to $18.7B with net income up 28.2% — exactly the earnings-visibility pillar of the thesis. The strongest point against is that the fundamental cash engine is fraying at the cluster's biggest names: Meta's free cash flow fell 86.8% quarter over quarter to $1.7B with net margin down 21.5 points to 26.1%, and its insiders sold roughly $54.7M net on the open market in the period ended June 30, 2026 (a passed reporting deadline, not a current reading), while Accenture's annual dividend has fallen 44.9% to $3.26 from $5.35 in 2024. The backtest is honest but thin — a 20.3% cumulative return on just 8 trades over 60 months with a 24.6% maximum drawdown — and parameter sensitivity testing ran out of its time budget, so no robust nearby setup was established. On the live tape, nothing is triggered: AKAM sits at $113.94 with RSI already at 56.2 (the entry needs RSI to reset below 40 and price back near the $109–110 band area), ACN's RSI is 36.5 but still below the 40 cross, and META is roughly $115 above its 50-day EMA at $636.72. The verdict flips to buy when AKAM pulls back into the $108.76–110 zone with RSI under 40 and then reclaims its 50-day EMA near $113.36; a confirmed AKAM margin miss or another leg of insider selling would flip it to avoid. Conviction breakdown: thesis support 62, trade readiness 30, risk quality 55, backtest evidence 50, fundamentals trend 48.

Trade now: the setup is close, but not live — here is exactly what has to click

The lead leg of this idea is AKAM, and it is the closest to firing, but no entry condition is fully live today. AKAM closed at $113.94, just $0.58 above its 50-day EMA at $113.36 — that condition is nearly in place. However, the RSI (14) trigger needs a fresh cross above 40, and RSI is already at 56.2, so the entry must wait for RSI to reset below 40 and turn back up. The band condition is also inverted right now: price must sit above the lower Bollinger band ($108.76) but below the middle band, meaning a pullback toward the $109–110 zone is what would arm the trade. What 'wait' means concretely: do not chase AKAM at $113.94. The trade arms on a pullback toward the $109–110 area followed by an RSI turn back above 40 and a close above the 50-day EMA near $113.36. Once filled, the strategy applies a fixed stop at 2.4% below entry and a take-profit at 4.7% above it — an effective reward-to-risk ratio of about 2-to-1 — with a structural stop also set below the second support level and a 90-bar time exit as a backstop. ACN ($176.11) is the second candidate and the weakest technically: RSI is 36.5, still below the 40 threshold, and price is only about $1.00 above its 50-day EMA at $175.11, so it needs both an RSI cross above 40 and a band pullback before it triggers. META ($751.66) is far away — RSI is 71.6 and price sits roughly $115 above its 50-day EMA at $636.72 — so treat META as a deep-pullback scenario, not a near-term setup. Evidence read: this is a backtested rule set. On AKAM daily bars over five years it produced a 20.3% cumulative return across 8 trades with a 62.5% win rate and a 24.6% maximum drawdown, which supports trading the trigger when it comes rather than pre-positioning. One honest caveat: sensitivity testing ran out of its time budget, so no robust nearby-parameter setup was established — trade the published rules as written.

Contracted AI revenue meets a rule set that has actually traded

The thesis rests on real, contracted AI demand, and the fundamentals back up the direction claim. Per Bloomberg's September 24 report, Akamai surged on a $12 billion Anthropic computing deal, and per Yahoo Finance, Accenture rallied after announcing a $1 billion AI partnership with Anthropic on September 23. CNBC separately noted Meta nearing its first new high in a year as Muse showcases a winning AI strategy. These are not projected revenues — they are signed commitments, which is exactly the earnings-visibility argument the idea makes. The balance sheets of the trio are unusually strong for an uncertain rate tape. Akamai sits at the 97th percentile of free cash flow among 832 Information Technology peers ($1.0B in the latest fiscal year) with a current ratio of 2.4; Accenture's free cash flow ranks at the 99th percentile ($3.8B in the latest quarter reported as of fiscal Q4, period ending August 31, 2025); and Meta carries a 38.0% net margin in its latest quarter — a cushion that lets these names absorb rate-driven multiple compression without earnings damage. Growth is also present where it matters most. Meta's revenue rose 8.0% quarter over quarter to $60.8B in the quarter ended June 30, 2026, with an 86.1% sector revenue-growth percentile; Akamai's revenue grew 2.4% sequentially to $1.1B, and Accenture's rose 3.7% to $18.7B with net margin expanding 2.4 points to 12.5%. The idea argues these catalysts attract rotation in risk-off conditions, and rising margins plus expanding revenue are consistent with demand holding up. On the trade side, this is a backtested setup, and the completed backtest statistics are the evidence read: over a 60-month window the AKAM-led leg produced a 20.3% return across 8 trades with…

Scores

• Conviction score breakdown: 49
• Thesis support: 62
• Trade readiness: 30
• Risk quality: 55
• Backtest evidence: 50
• Fundamentals trend: 48

Watch items

• AKAM — RSI (14)
• AKAM — Close price
• AKAM — Net income, next quarterly print
• ACN — RSI (14)
• ACN — Close price
• ACN — Insider open-market net value (next ownership filing)
• META — Close price
• META — Free cash flow, next quarterly print